Astrana Health
ASTH
36 hedge funds and large institutions have $47.6M invested in Astrana Health in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 8
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
9% more capital invested
Capital invested by funds: $43.7M → $47.6M (+$3.82M)
1.29% more ownership
Funds ownership: 6.67% → 7.96% (+1.3%)
3% less funds holding
Funds holding: 37 → 36 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$6.57M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.86M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
+$853K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$581K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$217K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
-$419K |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$224K |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
-$208K |
| 4 |
State Street
Boston,
Massachusetts
|
-$186K |
| 5 |
MF
Manchester Financial
Westlake Village,
California
|
-$182K |
ASTH Hedge Fund Activity: Q2 2019 in Review
36 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Astrana Health (ASTH) for Q2 2019, worth a combined $47.6M — up 8.7% from $43.7M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ASTH positions and 5 closed out — a net gain of 1 holder — while 16 added to existing stakes and 8 trimmed.
The largest buyer was BlackRock, adding an estimated $6.57M. The largest seller was Royce & Associates, exiting entirely with an estimated $419K sold.
- 36 institutional investors held Astrana Health (ASTH) as of Q2 2019, down from 37 in Q1 2019.
- Funds reported $47.6M of Astrana Health stock for Q2 2019, up 8.7% quarter-over-quarter.
- 6 funds opened new Astrana Health positions in Q2 2019 and 5 closed out, a net change of +1 holder.
- The largest Astrana Health buyer in Q2 2019 was BlackRock, an estimated $6.57M added.
- The largest Astrana Health seller in Q2 2019 was Royce & Associates, an estimated $419K sold.
Based on aggregated 13F filings for Q2 2019.